BioTelemetry Inc. has entered into an agreement to acquire a Swiss competitor for $257.4 million in a deal involving two companies that both specialize in remote cardiac monitoring technology and services.
Under the terms of the agreement,BioTelemetry (NASDAQ: BEAT) of Malvern, Pa., and will launch a tender offer in Switzerland to acquire all of the outstanding shares of LifeWatch. LIfeWatch shareholders will receive either 10 Swiss francs and 0.1457 shares of BioTelemetry stock per LifeWatch share,…
Source: bizjournals.com